MO SB1682

Veterans and first responders age 21+ with PTSD, major depressive disorder, substance use disorders, or requiring end-of-life care may legally use psilocybin for therapeutic purposes if enrolled in a study, supervised by a qualified facilitator, and limited to 150 milligrams annually

Facilitators must be licensed healthcare professionals (physicians, psychologists, clinical social workers, nurse practitioners, etc.) who have completed at least 30 hours of psilocybin-specific training consistent with American Psychological Association or American Psychedelic Practitioners Association guidelines

Department of Mental Health shall provide $2 million in grants for psilocybin research and conduct studies in collaboration with university hospitals or FDA-approved contract research organizations on psilocybin efficacy for veterans and first responders

Physicians and healthcare providers are protected from criminal/civil liability and professional license discipline for participating in approved psilocybin therapy or studies, except in cases of gross negligence or willful misconduct

Expands existing "Right to Try" law for investigational drugs by removing the exclusion of Schedule I controlled substances and extending eligibility beyond terminal illness to include life-threatening and severely debilitating conditions